Skip to main content

Table 2 Pathological results at 3 months and 1 year post-transplantation

From: Effects of antirejection therapies for early subclinical acute rejection in renal transplant protocol biopsies

3 months

1 year

p-value

NR

BL

SAR

Group A

 NR (n = 166)

108 (65.1)

50 (30.1)

8 (4.8)

 

Group B

 BL-o (n = 50)

24 (48.0)

23 (46.0)

3 (6.0)

0.011

 BL-t (n = 33)

19 (57.6)

11 (33.3)

3 (9.1)

 

 SAR (n = 20)

11 (55.0)

4 (20.0)

5 (25.0)

 

Total (n = 269)

162 (60.2)

88 (32.7)

19 (7.1)

 
  1. Data are presented as n (%).
  2. NR normal findings, BL borderline changes, SAR subclinical acute rejection, BL-t borderline changes with antirejection therapies, BL-o borderline changes with observation and no antirejection therapies
Back to article page

Renal Replacement Therapy

ISSN: 2059-1381

Contact us